Previous close | 227.40 |
Open | 222.98 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 222.98 - 229.05 |
52-week range | 166.94 - 261.42 |
Volume | |
Avg. volume | 1,650 |
Market cap | 453.546M |
Beta (5Y monthly) | 1.52 |
PE ratio (TTM) | 0.41 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
RESEARCH TRIANGLE PARK, N.C., April 15, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO, CA, April 08, 2024--IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce (NYSE:CRM), the #1 AI CRM, today announced an expanded global strategic partnership to accelerate the development of Salesforce’s Life Sciences Cloud, a next-generation customer engagement platform for the global life sciences industry.
RESEARCH TRIANGLE PARK, N.C., March 06, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays 26th Annual Global Healthcare Conference in Miami on Wednesday, March 13, 2024 at 9:30 a.m. ET.